1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Topics

Showing 1,267 results.

MM - 845

THE IMPACT OF FIRST-LINE DARATUMUMAB ON LIGHT-CHAIN AMYLOIDOSIS SURVIVAL: A REAL-WORLD ANALYSIS OF 70 PATIENTS

Fruzsina Sz?l

Poster Presenter: Fruzsina Sz?l

$Thumbnail for Treatment-Related Mortality and Predictors in Real-World Patients With Relapsed/Refractory Multiple Myeloma Treated With Teclistamab$

MM - 846

Treatment-Related Mortality and Predictors in Real-World Patients With Relapsed/Refractory Multiple Myeloma Treated With Teclistamab

Osama Younis

Poster Presenter: Osama Younis

Thumbnail for GLP-1 Receptor Agonists and SGLT2 Inhibitors in Multiple Myeloma and Plasma Cell Disorders: Protective, Harmful, or Both? A Scoping Review

MM - 852

GLP-1 Receptor Agonists and SGLT2 Inhibitors in Multiple Myeloma and Plasma Cell Disorders: Protective, Harmful, or Both? A Scoping Review

Yagnapriya Chirrareddy

Poster Presenter: Yagnapriya Chirrareddy

Thumbnail for IVIG Replacement Therapy and Clinical Outcomes in Adults With Hematologic Malignancies and Secondary Hypogammaglobulinemia: A Propensity Score-Matched Analysis

MM - 856

IVIG Replacement Therapy and Clinical Outcomes in Adults With Hematologic Malignancies and Secondary Hypogammaglobulinemia: A Propensity Score-Matched Analysis

Israr Khan

Poster Presenter: Israr Khan

Thumbnail for Survival and Cardiovascular Outcomes Associated With GLP-1 Receptor Agonist Exposure in Patients With Multiple Myeloma and Metabolic Comorbidities: A Propensity-Matched TriNetX Analysis

MM - 857

Survival and Cardiovascular Outcomes Associated With GLP-1 Receptor Agonist Exposure in Patients With Multiple Myeloma and Metabolic Comorbidities: A Propensity-Matched TriNetX Analysis

Nnamdi Omenuko

Poster Presenter: Nnamdi Omenuko

MM - 870

Isolated CNS Relapse Despite Systemic CR Following Extramedullary Disease in Primary Plasma Cell Leukemia

Sabaa Saad-Omer

Poster Presenter: Sabaa Saad-Omer

Thumbnail for Rising Fall- and Fracture-Associated Mortality Despite Declining Overall Multiple Myeloma Mortality in the United States, 2018-2024: National Trends, Fracture-Site Burden, and Disparities

MM - 878

Rising Fall- and Fracture-Associated Mortality Despite Declining Overall Multiple Myeloma Mortality in the United States, 2018-2024: National Trends, Fracture-Site Burden, and Disparities

Ayse Gul Korkmaz

Poster Presenter: Ayse Gul Korkmaz

$Thumbnail for Real-World Safety Profile of Ciltacabtagene Autoleucel in Triple-Class Refractory Multiple Myeloma: A TriNetX Analysis.$

MM - 881

Real-World Safety Profile of Ciltacabtagene Autoleucel in Triple-Class Refractory Multiple Myeloma: A TriNetX Analysis.

Hira Cheema

Poster Presenter: Hira Cheema

$Thumbnail for Outcomes of Bispecific Antibody Rescue Therapy Following CAR-T Cell Therapy Failure in Relapsed/Refractory Multiple Myeloma: A Systematic Review and Meta-Analysis$

MM - 890

Outcomes of Bispecific Antibody Rescue Therapy Following CAR-T Cell Therapy Failure in Relapsed/Refractory Multiple Myeloma: A Systematic Review and Meta-Analysis

Pragya Jain

Poster Presenter: Pragya Jain